| Literature DB >> 11884422 |
Nathalie Scholler1, Martha Hayden-Ledbetter, Amber Dahlin, Ingegerd Hellström, Karl Erik Hellström, Jeffrey A Ledbetter.
Abstract
We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8(+) T cells. We injected CD83-Ig into mice transplanted with the immunogenic P815 mastocytoma and showed that it significantly enhanced the rate of tumor growth and inhibited the development of cytotoxic T cells. In contrast, mice immunized with CD83-transfected K1735 cells, a poorly immunogenic melanoma, could prevent the outgrowth of wild-type K1735 cells. Studies performed in vitro with human PBL showed that coimmobilized CD83-Ig and anti-CD3 enhanced T cell proliferation and increased the proportion of CD8(+) T cells. CD83-transfected B-lymphoblastoid T51 cells stimulated T cell proliferation more effectively than untransfected T51 cells in MLR cultures and increased the generation of cytolytic T cells. We conclude that CD83 is a functionally important receptor that can regulate the development of cellular immunity by interacting with its ligand(s).Entities:
Mesh:
Substances:
Year: 2002 PMID: 11884422 DOI: 10.4049/jimmunol.168.6.2599
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422